NEWS
You can follow the latest news of MicroViable in this section
Microviable attending BIO 2025
Microviable Therapeutics will be attending Bio International Convention 2025 in Boston Claudio Hidalgo, PhD., cofounder and CEO, will be attending the BIO International Convention 2025 event, taking place in Boston during June 16th-19th. This four-day [...]
Pilar Manrique, PhD contributed to opinion article at GEN News
Genetic Engineering and Biotechnolgy News is one of the leading journals in biotechnology, showcasing groundbreaking technologies and the latest advanced in the biotech field. Check out the latest article published at the prestigious journal and [...]
Microviable present at The Microbiome Times Partnering Forum
Microviable Therapeutics will be at The Microbiome Times Partnering Forum taking place in Brussels on March 18-19th 2025. Claudio Hidalgo, PhD., cofounder and CEO, and David Ríos Covián, PhD., CTO will be attending The Microbiome [...]
Pilar Manrique will present at 9th Microbiome Movement Summit
Pilar Manrique, senior scientist at Microviable Therapeutics will be present at 9th Microbiome Microbiome Movement Summit taking place in Barcelona in January 28-30th 2025! The Summit explored the latest advances in microbiome science, where innovative [...]
Microviable Therapeutics expands leadership team with Chief Financial Officer
Gijón, Spain, September 23rd 2024 – Microviable Therapeutics, a biotech company developing novel biological drugs for infectious diseases and oncology, announced today the appointment of Mehdi Chouikh Skalli as Chief Financial Officer. Mehdi Chouikh has [...]
World Cancer Research Day: Exploring Microbiome-Based Cancer Therapies
On September 24th, we join the global community in recognizing World Cancer Research Day (WCRD)—an international movement dedicated to highlighting the critical role of cancer research in driving breakthroughs for cancer control and treatment. This [...]